Chugai Pharmaceutical Co., Ltd. (CHGCF)
37.68
+0.51
(+1.37%)
USD |
OTCM |
Oct 09, 16:00
Chugai Pharmaceutical Price to Book Value : 4.970 for Oct. 9, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 09, 2026 | 4.970 |
| October 08, 2026 | 4.902 |
| October 07, 2026 | 5.046 |
| October 06, 2026 | 5.098 |
| October 05, 2026 | 5.181 |
| October 02, 2026 | 5.047 |
| October 01, 2026 | 4.990 |
| September 30, 2026 | 5.347 |
| September 29, 2026 | 5.221 |
| September 28, 2026 | 5.334 |
| September 25, 2026 | 5.475 |
| September 24, 2026 | 5.380 |
| September 23, 2026 | 5.614 |
| September 22, 2026 | 5.699 |
| September 21, 2026 | 5.717 |
| September 18, 2026 | 5.488 |
| September 17, 2026 | 5.614 |
| September 16, 2026 | 4.651 |
| September 15, 2026 | 5.431 |
| September 14, 2026 | 5.702 |
| September 11, 2026 | 5.638 |
| September 10, 2026 | 5.256 |
| September 09, 2026 | 5.456 |
| September 08, 2026 | 5.767 |
| September 04, 2026 | 5.716 |
| Date | Value |
|---|---|
| September 03, 2026 | 5.803 |
| September 02, 2026 | 5.486 |
| September 01, 2026 | 5.460 |
| August 31, 2026 | 5.837 |
| August 28, 2026 | 5.856 |
| August 27, 2026 | 5.774 |
| August 26, 2026 | 5.655 |
| August 25, 2026 | 5.593 |
| August 24, 2026 | 5.920 |
| August 21, 2026 | 5.543 |
| August 20, 2026 | 5.682 |
| August 19, 2026 | 5.648 |
| August 18, 2026 | 5.501 |
| August 17, 2026 | 5.907 |
| August 14, 2026 | 5.699 |
| August 13, 2026 | 5.748 |
| August 12, 2026 | 5.796 |
| August 11, 2026 | 5.677 |
| August 10, 2026 | 5.869 |
| August 07, 2026 | 5.656 |
| August 06, 2026 | 5.729 |
| August 05, 2026 | 5.455 |
| August 04, 2026 | 5.760 |
| August 03, 2026 | 5.577 |
| July 31, 2026 | 5.694 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 1.273 |
| Daiichi Sankyo Co., Ltd. | 2.910 |
| Eisai Co., Ltd. | 1.477 |
| Santen Pharmaceutical Co., Ltd. | 1.859 |
| Ono Pharmaceutical Co., Ltd. | 1.253 |
Price to Book Value Related Metrics
| PE Ratio | 20.31 |
| PS Ratio | 7.127 |
| PEG Ratio | 1.314 |
| Price to Free Cash Flow | 26.50 |
| Price | 37.68 |
| Earnings Yield | 4.92% |
| Market Cap | 62.00B |
| PEGY Ratio | 1.067 |
| Operating PE Ratio | 14.13 |
| Normalized PE Ratio | 19.39 |